© 2021 The Regents of the University of Colorado, a body corporate.
All rights reserved. All trademarks are registered property of the University. Used by permission only.
The Colorado Consortium for prescription drug abuse prevention provider education workgroup seeks to engage and educate a broad range of health care providers across Colorado. More specifically, the goal of the workgroup is to increase knowledge around pain management, safe opioid prescribing, and substance use disorder treatment by using a variety of educational tools.
|Introduction to Opioids and Benzodiazepines||Non-Opioid Pain Management Strategies||Substance Use Disorder Treatment||Other|
|Clinical Pearls for Safe Opioid Prescribing||Non-Opioid Pain Management||Introduction to Substance Use Disorder and Medication Assisted Treatment||Motivational Interviewing for Discontinuing Opioids|
|Opioid Reduction and Discontinuation Strategies||Acupuncture||Addiction: A Personal Journey||Pelvic Pain for the Primary Care Physician|
|Benzos: Boon or Blunder?||Behavioral Aspects of Pain||Alcohol Use Disorder: Outpatient Management (coming soon)||Sleep Disorders and Chronic Pain (coming soon)|
|Physical Therapy Role in Pain Management||MAT and Stimulant Use Disorder: From Harm Reduction to Treatment (coming soon)||Perinatal Addiction Pearls and Updates (coming soon)|
|Fibromyalgia||Trauma and Substance Use Disorder (coming soon)|
|Low Back Pain||Benzodiazepines: The Patient Perspective (coming soon)|
ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Colorado Medical Society and North Colorado Health Alliance. The Colorado Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
Disclosure of Relevant Financial Relationships
The planners, faculty, and all others in control of the content of this CME activity have reported no financial relationships with commercial interests that would create a conflict of interest for CME purposes with the following exceptions:
Release Date: 8/1/2020
Termination Date: 5/31/2023
Review Date: 4/30/2023